1. Design and synthesis of glyco-peptides as anti-cancer agents targeting thrombin-protease activated receptor-1 interaction
- Author
-
Jen-Chine Wu, Chi-Huey Wong, Alice L. Yu, Hua-Ting Hsu, Ying-Ta Wu, Yu-Hsuan Chang, Cheng-Der Tony Yu, and Hui-Ming Yu
- Subjects
Glycan ,Antineoplastic Agents ,Mice, SCID ,Catalysis ,03 medical and health sciences ,0302 clinical medicine ,Thrombin ,Cell Line, Tumor ,Neoplasms ,Materials Chemistry ,medicine ,Animals ,Humans ,Tumor growth ,Receptor, PAR-1 ,030304 developmental biology ,0303 health sciences ,biology ,Chemistry ,Metals and Alloys ,Glycopeptides ,Active site ,Cancer ,General Chemistry ,medicine.disease ,Surfaces, Coatings and Films ,Electronic, Optical and Magnetic Materials ,Protease-Activated Receptor 1 ,Coagulation ,Biochemistry ,030220 oncology & carcinogenesis ,Drug Design ,Ceramics and Composites ,biology.protein ,medicine.drug - Abstract
Thrombin activates protease-activated receptor-1 (PAR-1) through binding to exosite I and the active site to promote tumor growth. We have developed a new class of anti-cancer glyco-peptides to target exosite I selectively without affecting the active-site-mediated coagulation activity and showed the importance of glycans for the stability and anti-cancer activity of the glyco-peptides.
- Published
- 2020